Related Experiment Video
Updated: Jun 11, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Hypoxic Signaling Is Modulated by Calcium Channel, CaV1.3, in Androgen-Resistant Prostate Cancer
Debbie O'Reilly1, Paul J Buchanan1
1DCU Cancer Research Group, National Institute Cellular Biotechnology, School of Nursing, Psychotherapy and Community Health, Dublin City University (DCU), Dublin, Ireland.
Calcium channel CaV1.3 influences hypoxia-inducible factor (HIF) signaling in prostate cancer (PCa) progression. Targeting CaV1.3 may offer new strategies for treating advanced castrate-resistant prostate cancer (CRPC).
Area of Science:
- Oncology
- Molecular Biology
- Calcium Signaling
Background:
- Androgen deprivation therapy (ADT) is crucial for advanced prostate cancer (PCa) but can lead to castrate-resistant prostate cancer (CRPC).
- Hypoxic tumor microenvironments and hypoxia-inducible factor (HIF) signaling are implicated in CRPC development.
- Intracellular calcium, particularly store-operated calcium entry (SOCE) via CaV1.3, is modulated by ADT and may influence hypoxic signaling.
Purpose of the Study:
- To explore the role of the voltage-gated calcium channel, CaV1.3, in supporting hypoxic signaling and CRPC biology.
- To investigate the impact of ADT on CaV1.3 expression and SOCE.
- To determine how CaV1.3 affects HIF signaling and CRPC cell behavior under hypoxic conditions.
Main Methods:
- Cultured androgen-sensitive PCa LNCaP cells and ADT-resistant CRPC cells under normal and hypoxic (1% O2) conditions.
- Measured gene and protein expression of HIF-1α, CaV1.3, and androgen receptor (AR) using qPCR and Western blot.
- Assessed SOCE, cell proliferation, and cell survival with Fura-2AM fluorescence, WST-1 assay, and colony formation assays, respectively, with and without CaV1.3 inhibition (siCaV1.3).
Main Results:
- CaV1.3 expression and SOCE increased with ADT.
- HIF-1α was upregulated by ADT and further increased under hypoxia, with a greater fold change in resistant cells.
- CaV1.3 inhibition reduced HIF-1α and AR expression in ADT-sensitive cells but increased them in CRPC cells under hypoxia.
- CaV1.3 inhibition significantly reduced cell survival in all cell types under hypoxia and reduced proliferation in CRPC cells.
Conclusions:
- CaV1.3 modulates HIF signaling and impacts prostate cancer tumor biology under hypoxia.
- The precise mechanism by which CaV1.3 influences HIF signaling (via SOCE or noncanonical pathways) requires further investigation.
- CaV1.3 inhibition shows potential for reducing CRPC cell survival and proliferation, particularly under hypoxic conditions.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Regulation of Angiogenesis and Blood Supply
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Antihypertensive Drugs: Action of Calcium Channel Blockers